拉夏貝爾(06116.HK)實控人邢加興所持1.42億股A股被輪候凍結
格隆匯8月17日丨拉夏貝爾(06116.HK)公佈,公司於2020年8月17日收到《股權司法凍結及司法劃轉通知》及上海金融法院《協助執行通知書》,獲悉公司控股股東、實際控制人邢加興先生所持有的公司有限售條件A股股份1.42億股被輪候凍結。
經公司向邢加興先生核實,本次輪候凍結與邢加興先生將所持有1.42億股A股股份股質押給海通證券有關,因其未履行回購或履約保障措施,海通證券向上海金融法院申請輪候凍結邢加興先生持有的1.42億股A股股份。目前邢加興先生正在積極與質權人海通證券進行溝通,爭取儘快達成和解或有效解決方案,公司將密切關注該事項進展並及時履行信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.